Success Stories
    Switching

    GLP-1 Success: Switching Medications

    Sometimes the first GLP-1 medication is not the right fit. Real stories from patients who found better results by switching.

    Last updated: March 25, 2026-10 min read

    Not every patient has a straight-line weight loss journey on their first GLP-1 medication. Plateaus happen. Side effects persist. Results underwhelm. The key is having a provider who can pivot -- switching you to a different medication when the first one is not delivering. Trimi is the only provider offering all three GLP-1 medications, making seamless transitions possible.

    When Should You Consider Switching?

    Signs It Might Be Time to Switch

    • Weight loss plateau: Less than 1 lb/week for 6+ consecutive weeks at maximum dose
    • Persistent side effects: GI symptoms that do not improve after 8+ weeks at stable dose
    • Insufficient results: Less than 5% weight loss after 3 months at therapeutic dose
    • Changed goals: Need more aggressive weight loss than current medication provides
    • Cost optimization: Stepping down to a less expensive option for maintenance

    Switching Success Stories

    Angela, 41 -- Semaglutide to Tirzepatide: Lost 78 lbs total

    Semaglutide: 8 months, lost 35 lbs | Tirzepatide: 7 months, lost 43 more lbs

    "Semaglutide got me started -- I lost 35 pounds and felt great. Then the scale stopped moving for 2 months despite being at 2.4mg. My Trimi doctor switched me to tirzepatide at 5mg and the weight started falling off again. The dual mechanism hit different for my body. Total loss of 78 pounds across both medications. Having a provider who could switch me without starting over was huge."

    Kevin, 47 -- Tirzepatide to Semaglutide: Better Tolerance

    Tirzepatide: 3 months, lost 25 lbs but severe nausea | Semaglutide: 9 months, lost 40 more lbs

    "Tirzepatide was effective but the nausea was unbearable -- even at 5mg I could barely keep food down. My doctor switched me to semaglutide and the GI issues were much more manageable. I lost weight slower but consistently, and I actually felt good doing it. Sometimes the strongest medication is not the right one for your body. I saved money too -- $99/month instead of $125."

    Diana, 52 -- Tirzepatide to Semaglutide for Maintenance

    Tirzepatide: 12 months, lost 65 lbs | Semaglutide: Ongoing maintenance

    "I reached my goal weight on tirzepatide 10mg. For maintenance, my doctor suggested trying semaglutide at a lower dose to save $26/month. It has worked perfectly -- I have maintained my weight loss for 6 months on semaglutide 1.7mg at $99/month. Using the more potent drug for weight loss and the less expensive one for maintenance makes financial sense."

    How Switching Works at Trimi

    Seamless Transition Process

    • Step 1: Discuss switching with your Trimi physician based on your results
    • Step 2: Provider determines appropriate starting dose for new medication
    • Step 3: Stop current medication, start new one the following week
    • Step 4: Closer monitoring during first 4 weeks of transition
    • Step 5: Resume normal titration schedule on new medication

    The Flexibility to Find What Works

    Trimi offers semaglutide ($99/mo), tirzepatide ($125/mo), and retatrutide -- with seamless switching and no restart penalties.

    Explore Options

    Medical Disclaimer

    This article is for informational purposes only. Switching between GLP-1 medications should only be done under physician supervision. Individual results vary. Always consult your healthcare provider before changing medications.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: December 25, 2025

    TMT

    Written by Trimi Medical Team

    Our team of healthcare professionals specializes in weight management and metabolic health, providing evidence-based information to help you make informed decisions about your health journey.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Buy compounded semaglutide online in Texas for $99/month. Learn about Texas telehealth laws, compounding pharmacy access, and how to start affordable GLP-1 weight loss treatment.

    Buy compounded semaglutide online in Florida for $99/month. Florida telehealth access, compounding pharmacy regulations, and affordable GLP-1 weight loss treatment.

    Buy compounded semaglutide online in Illinois for $99/month. Chicago and statewide telehealth access to affordable GLP-1 weight loss treatment.

    Buy compounded tirzepatide online in Texas for $125/month. Dual-action GLP-1/GIP weight loss medication delivered to your door via licensed telehealth.

    Start your GLP-1 journey — from $99/mo

    Get Started